Patent application number | Description | Published |
20080200802 | PLATFORM FOR DETECTION OF TISSUE CONTENT AND/OR STRUCTURAL CHANGES WITH CLOSED-LOOP CONTROL IN MAMMALIAN ORGANISMS - Aspects include methods and apparatuses for effecting change over time in one or more measured regions of a body using a plurality of data sets obtained by analysis of applied signals to said region and effecting a change in treatment protocol. The method may include transmitting and receiving one or more of electromagnetic wave signals, applied acoustic wave signals and electrical signals transmitted through or reflected off of a portion of the measured body region. Some aspects may include determining a change in tissue structure, or a change in tissue content. | 08-21-2008 |
20100268111 | MONITORING PLATFORM FOR WOUND AND ULCER MONITORING AND DETECTION - Systems and techniques for monitoring hydration. In one implementation, a method includes measuring an electrical impedance of a region of a subject to generate an impedance measurement result, and wirelessly transmitting the data to a remote apparatus. The probe with which impedance is measured may in the form of a patch adhesively secured to the subject. | 10-21-2010 |
20100324415 | PLATFORM FOR DETECTION OF TISSUE STRUCTURE CHANGE - Aspects include methods and apparatuses for determining change over time in one or more measured regions of a body using a plurality of data sets obtained by analysis of applied signals to said region. The method may include transmitting and receiving one or more of electromagnetic wave signals, applied acoustic wave signals and electrical signals transmitted through or reflected off of a portion of the measured body region. | 12-23-2010 |
20120041355 | MULTIPLE SECTION PARENTERAL DRUG DELIVERY APPARATUS - The invention relates to a parenteral therapeutic agent delivery device. The therapeutic agent delivery device has a disposable section and an implant section suitable for long term implantation within the tissue of a subject. When necessary, the disposable section can be detached from the implant section, and a new disposable section can be attached. The disposable section may contain a reservoir containing the therapeutic agent, a pump for dispensing the therapeutic agent, controlling circuitry for regulating the dispensing of the therapeutic agent, and transceiver circuitry and an antenna for wireless communication with external devices. | 02-16-2012 |
Patent application number | Description | Published |
20100049004 | Metabolic energy monitoring system - A metabolic energy monitoring system having one or more physiological measurement platforms and displays enabling the calculation and display of energy balance, kilocalorie energy expenditure and kilocalorie intake is described. In preferred embodiments, the system utilizes one or more on-body monitoring platforms to enable measurement of change in body composition and kilocalorie energy expenditure over a period of time thereby enabling a comparator to calculate net energy balance over this period of time and to calculate kilocalorie intake over this same period of time. Such data may then be displayed on a display device in wireless communication with the on-body monitoring platform to provide the user of the system with useful information and guidance in weight management applications. | 02-25-2010 |
20100100160 | Methods and devices for self adjusting phototherapeutic intervention - The present invention relates to devices for the sensing of one or more body regions within a larger body zone, and the application of a therapy, preferably photonic therapy, based upon one or more sensor measurements derived from at least one body region. Such applied photonic therapies may be accomplished in an effectively simultaneous fashion while being adjusted independently to each body region. In addition, successive applications of photonic therapy(s) to one or more body regions may be further adjusted based upon one or more successive sensor measurements of the corresponding body regions. | 04-22-2010 |
20110208067 | Vascular patency management using electric fields - The invention relates to the management of vascular patency by the use of implanted devices delivering one or more energies to a target vascular tissue wherein such energy delivery sources are substantially located in the vicinity of a target vascular region. The invention preferably employs electric currents as energy and utilizes one or more electrodes positioned in the vicinity of a target region and one or more electrodes located elsewhere. Such devices may be useful in the management of stenotic lesion formation adversely associated with a loss of patency in a variety of disease states or conditions, including vascular patency needed for hemodialysis used in the treatment of kidney failure. | 08-25-2011 |
20110224578 | USE OF ELECTRIC FIELDS TO MINIMIZE REJECTION OF IMPLANTED DEVICES AND MATERIALS - This invention relates to the electric field method to reduce fibrous capsule formation adjacent to the surface of implanted medical devices and associated apparatus for generating electrical currents to reduce fibrous capsule formation. The invention has utility with medical devices or systems such as those providing long term parenteral drug delivery, fluid infusion or analyte sampling/measurement. The apparatus of the invention may be constructed as a part of the medical device or may be constructed of separate elements while providing the benefit of the electric fields to the medical device. | 09-15-2011 |
20110224912 | Physiological Monitor System for Determining Medication Delivery and Outcome - A method is described for the determination of the taking of a medication utilizing at least one physiological parameter monitoring platform. In addition, the method also may enable the determination of physiological effects or events resultant from the taking of a medication (or lack thereof) through the use of one or more physiological monitoring platforms. | 09-15-2011 |
20110230732 | System utilizing physiological monitoring and electronic media for health improvement - The present invention generally relates to the use of physiological monitoring to enable an individualized response, e.g. feedback, recommendations, rewards or guidance to be presented to the individual within the context of electronic media. Specifically, the response is preferably based upon measured physiological data obtained while the individual is not directly involved with the electronic media and is preferably delivered in the context of an electronic game or interactive social activity program. | 09-22-2011 |
20140017644 | SYSTEM UTILIZING PHYSIOLOGICAL MONITORING AND ELECTRONIC MEDIA FOR HEALTH IMPROVEMENT - The present invention generally relates to the use of physiological monitoring to enable an individualized response, e.g. feedback, recommendations, rewards or guidance to be presented to the individual within the context of electronic media. Specifically, the response is preferably based upon measured physiological data obtained while the individual is not directly involved with the electronic media and is preferably delivered in the context of an electronic game or interactive social activity program. | 01-16-2014 |
20140343861 | METABOLIC ENERGY MONITORING SYSTEM - A metabolic energy monitoring system having one or more physiological measurement platforms and displays enabling the calculation and display of energy balance, kilocalorie energy expenditure and kilocalorie intake is described. In preferred embodiments, the system utilizes one or more on-body monitoring platforms to enable measurement of change in body composition and kilocalorie energy expenditure over a period of time thereby enabling a comparator to calculate net energy balance over this period of time and to calculate kilocalorie intake over this same period of time. Such data may then be displayed on a display device in wireless communication with the on-body monitoring platform to provide the user of the system with useful information and guidance in weight management applications. | 11-20-2014 |
Patent application number | Description | Published |
20120019161 | LIGHT-EMITTING ELECTROCHEMICAL CELL AND SYSTEM, USE THEREOF AND METHOD FOR THEIR OPERATION - A light-emitting device comprises a first electrode, a second electrode, and a light-emitting active material contacting and separating the first and second electrodes. The device comprises a combination of a conjugated polymer and an electrolyte, said electrolyte comprising ions, allowing for electrochemical doping of the conjugated polymer. In the device, a ratio between the ions and the conjugated polymer is selected to allow for the formation of:
| 01-26-2012 |
20120228597 | LIGHT-EMITTING ELECTROCHEMICAL DEVICE, A SYSTEM COMPRISING SUCH A DEVICE AND USE OF SUCH A DEVICE - A light-emitting device is provided having an anode, a cathode, and a light-emitting material contacting and separating the cathode and anode. Wherein the cathode includes a graphene and/or graphene oxide. | 09-13-2012 |
20150243920 | METHOD FOR MANUFACTURING A LIGHT-EMITTING ELECTROCHEMICAL CELL - A method for manufacturing a light-emitting electrochemical cell (LEC) is disclosed. The LEC comprises a first electrode, a second electrode, and a first light-emitting active material in electrical contact with and separating the first and second electrodes. The first active material comprises mobile ions in an amount sufficient for doping the active material. The method comprises a step of depositing the first active material by spray-coating at an ambient gas pressure of at least about 1 kPa. | 08-27-2015 |
Patent application number | Description | Published |
20120171221 | BIOMARKERS FOR THE EARLY DETECTION OF AUTOIMMUNE DISEASES - Provided are methods for aiding in diagnosing autoimmune diseases in a mammal, comprising contacting a sample of tear from the mammal with an antibody that specifically binds to a first polypeptide selected from the group Ctss, Ctsh, Ctsr, Ctsw, Ctsz, Ifng, Il16ra, Il10, Il10ra, Il15, Tnfa, Apo-F, or Lcn-2 or a second polypeptide selected from the group lactoperoxidase, lactoferrin or lysozyme under conditions favoring the formation of an antibody-polypeptide complex, and determining the amount of complex formed, wherein an increased formation of antibody-first-polypeptide complex or a decreased formation of antibody-second-polypeptide complex as compared to a suitable control, indicates a likely positive diagnosis of an autoimmune disease for the mammal, thereby aiding in the diagnosis. Methods of treating the autoimmune diseases are also provided. | 07-05-2012 |